i brd9 Search Results


i-brd9  (MuseChem Chemicals)
N/A
I-BRD9（Cat No.:I002236）is a selective chemical inhibitor of BRD9, a bromodomain-containing protein within the ncBAF chromatin-remodeling complex. By blocking BRD9’s ability to recognize acetylated histones, I-BRD9 disrupts transcriptional programs involved in cell identity, proliferation, and oncogenic
   Buy from Supplier
i-brd9  (1PlusChem LLC)
N/A
I-BRD9
   Buy from Supplier
i brd9  (Selleck Chemicals)
93
Selleck Chemicals i brd9
I Brd9, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i+brd9/pmc11919606-43-0-2?v=Selleck+Chemicals
Average 93 stars, based on 1 article reviews
i brd9 - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
i brd9  (Tocris)
90
Tocris i brd9
Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and <t> I-BRD9 </t> in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).
I Brd9, supplied by Tocris, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i+brd9/pmc05536025-143-0-1?v=Tocris
Average 90 stars, based on 1 article reviews
i brd9 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
brd9 binder  (DiscoverX corporation)
90
DiscoverX corporation brd9 binder
Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and <t> I-BRD9 </t> in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).
Brd9 Binder, supplied by DiscoverX corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i+brd9/pmc04885110-16-33-55?v=DiscoverX+corporation
Average 90 stars, based on 1 article reviews
brd9 binder - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
brd9 inhibitor i-brd9 sml1534  (Merck KGaA)
90
Merck KGaA brd9 inhibitor i-brd9 sml1534
Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and <t> I-BRD9 </t> in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).
Brd9 Inhibitor I Brd9 Sml1534, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i+brd9/pmc11518989__41375_2024_2379_MOESM1_ESM-122-10-19?v=Merck+KGaA
Average 90 stars, based on 1 article reviews
brd9 inhibitor i-brd9 sml1534 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
bromodomain probe i-brd9  (Verlag GmbH)
90
Verlag GmbH bromodomain probe i-brd9
Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and <t> I-BRD9 </t> in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).
Bromodomain Probe I Brd9, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i+brd9/10__1002_slash_ange__201611281-42-18-7?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
bromodomain probe i-brd9 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
brd9  (Glaxo Smith)
86
Glaxo Smith brd9
Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and <t> I-BRD9 </t> in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).
Brd9, supplied by Glaxo Smith, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/i+brd9/10__1002_slash_anie__201611281-45-25-28?v=Glaxo+Smith
Average 86 stars, based on 1 article reviews
brd9 - by Bioz Stars, 2026-08
86/100 stars
  Buy from Supplier
i-brd9  (Aladdin Scientific Corporation)
N/A
I-BRD9 is developed from thienopyridone scaffold. It can also be used as an identifier for BRD9 regulated gene in Kasumi-1 cells involved in oncology and immune response pathways.
   Buy from Supplier
i-brd9  (Biosynth Carbosynth)
N/A
   Buy from Supplier
i-brd9  (MedChemExpress)
N/A
I-BRD9 is a selective cellular chemical probe of bromodomain-containing protein 9 (BRD9) with pIC50 value of 7.3 μM. I-BRD9 has high selectivity for bromodomain and extra terminal domain (BET) family and highly homologous bromodomain-containing protein
   Buy from Supplier

Image Search Results


Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and I-BRD9 in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).

Journal: International Journal of Molecular Sciences

Article Title: BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors

doi: 10.3390/ijms18071537

Figure Lengend Snippet: Half maximal inhibitory concentrations (IC 50 ) of BI-9564 and I-BRD9 in RT cell lines incubated for 72 or 144 h. Cell proliferation was evaluated by MTT cytotoxicity assays. ( n ≥ 3).

Article Snippet: I-BRD9 (Tocris Bioscience, Bristol, UK) and BI-9564 (Tocris Bioscience, Bristol, UK) were dissolved in Dimethyl Sulfoxide (DMSO) (AppliChem, Hannover, Germany) as stock solutions of 10 mM and aliquoted to only freeze thaw once.

Techniques: Incubation

Percentage of cells in G1 cell cycle phase after incubating with BI-9564 and I-BRD9 at the indicated concentrations for 72 h. ( n ≥ 3; mean ± SD; * treatment vs. control with p < 0.05, one-way ANOVA).

Journal: International Journal of Molecular Sciences

Article Title: BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors

doi: 10.3390/ijms18071537

Figure Lengend Snippet: Percentage of cells in G1 cell cycle phase after incubating with BI-9564 and I-BRD9 at the indicated concentrations for 72 h. ( n ≥ 3; mean ± SD; * treatment vs. control with p < 0.05, one-way ANOVA).

Article Snippet: I-BRD9 (Tocris Bioscience, Bristol, UK) and BI-9564 (Tocris Bioscience, Bristol, UK) were dissolved in Dimethyl Sulfoxide (DMSO) (AppliChem, Hannover, Germany) as stock solutions of 10 mM and aliquoted to only freeze thaw once.

Techniques: Control

Percentage of dead RT cells after incubation with different BI-9564 and I-BRD9 concentrations for 72 h. ( n ≥ 3; mean ± SD, * treatment vs. control with p < 0.05, one-way ANOVA).

Journal: International Journal of Molecular Sciences

Article Title: BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors

doi: 10.3390/ijms18071537

Figure Lengend Snippet: Percentage of dead RT cells after incubation with different BI-9564 and I-BRD9 concentrations for 72 h. ( n ≥ 3; mean ± SD, * treatment vs. control with p < 0.05, one-way ANOVA).

Article Snippet: I-BRD9 (Tocris Bioscience, Bristol, UK) and BI-9564 (Tocris Bioscience, Bristol, UK) were dissolved in Dimethyl Sulfoxide (DMSO) (AppliChem, Hannover, Germany) as stock solutions of 10 mM and aliquoted to only freeze thaw once.

Techniques: Incubation, Control

IC 50 and combination indices (CI) of combined treatments. Treatment of BT12 and G401 with combinations of I-BRD9 and three cytotoxic drugs for 72 h. CI < 1 indicates synergistic effects and CI > 1 antagonistic effects of combined drugs. R 2 represents the determination coefficient of linear regression in median effect plot. ( n ≥ 3).

Journal: International Journal of Molecular Sciences

Article Title: BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors

doi: 10.3390/ijms18071537

Figure Lengend Snippet: IC 50 and combination indices (CI) of combined treatments. Treatment of BT12 and G401 with combinations of I-BRD9 and three cytotoxic drugs for 72 h. CI < 1 indicates synergistic effects and CI > 1 antagonistic effects of combined drugs. R 2 represents the determination coefficient of linear regression in median effect plot. ( n ≥ 3).

Article Snippet: I-BRD9 (Tocris Bioscience, Bristol, UK) and BI-9564 (Tocris Bioscience, Bristol, UK) were dissolved in Dimethyl Sulfoxide (DMSO) (AppliChem, Hannover, Germany) as stock solutions of 10 mM and aliquoted to only freeze thaw once.

Techniques: